We found that the heat shock protein 90 (Hsp90) chaperone system of the yeast Saccharomyces cerevisiae is greatly impaired in naa10Δ cells, which lack the NatA N α -terminal acetylase (Nt-acetylase) and therefore cannot N-terminally acetylate a majority of normally N-terminally acetylated proteins, including Hsp90 and most of its cochaperones. Chk1, a mitotic checkpoint kinase and a client of Hsp90, was degraded relatively slowly in wild-type cells but was rapidly destroyed in naa10Δ cells by the Arg/N-end rule pathway, which recognized a C terminus-proximal degron of Chk1. Diverse proteins (in addition to Chk1) that are shown here to be targeted for degradation by the Arg/N-end rule pathway in naa10Δ cells include Kar4, Tup1, Gpd1, Ste11, and also, remarkably, the main Hsp90 chaperone (Hsc82) itself. Protection of Chk1 by Hsp90 could be overridden not only by ablation of the NatA Nt-acetylase but also by overexpression of the Arg/N-end rule pathway in wild-type cells. Split ubiquitin-binding assays detected interactions between Hsp90 and Chk1 in wild-type cells but not in naa10Δ cells. These and related results revealed a major role of Nt-acetylation in the Hsp90-mediated protein homeostasis, a strong up-regulation of the Arg/N-end rule pathway in the absence of NatA, and showed that a number of Hsp90 clients are previously unknown substrates of the Arg/N-end rule pathway. Naa10 | Chk1 | Ubr1 | Ufd4 | protein degradation P roteins called chaperones promote the in vivo protein folding and counteract misfolding, maladaptive protein aggregation, and other perturbations of proteostasis (1-4). Hsp90 is an ATPdependent chaperone system that mediates the conformational maturation and stabilization of many proteins. Referred to as Hsp90 clients, these proteins include kinases, transcriptional regulators, and many other proteins that comprise at least 20% of a cellular proteome. The diversity of Hsp90 clients and the broad range of processes that involve Hsp90 underlie its necessity for cell viability in all eukaryotes (5-11). Cochaperones of the ∼90-kDa Hsp90 comprise, in mammals, ∼30 distinct proteins. They participate in the delivery of clients to Hsp90 and contribute to related processes, including ATP hydrolysis by Hsp90 (12). Because of its ability to modulate protein conformations, the Hsp90 system can either exacerbate or counteract the fitness-reducing effects of mutations in cellular proteins. This property of Hsp90 affects the standing genetic variation and thereby influences the impact of natural selection on rates and directions of evolution (13, 14).
We found that the heat shock protein 90 (Hsp90) chaperone system of the yeast Saccharomyces cerevisiae is greatly impaired in naa10Δ cells, which lack the NatA N α -terminal acetylase (Nt-acetylase) and therefore cannot N-terminally acetylate a majority of normally N-terminally acetylated proteins, including Hsp90 and most of its cochaperones. Chk1, a mitotic checkpoint kinase and a client of Hsp90, was degraded relatively slowly in wild-type cells but was rapidly destroyed in naa10Δ cells by the Arg/N-end rule pathway, which recognized a C terminus-proximal degron of Chk1. Diverse proteins (in addition to Chk1) that are shown here to be targeted for degradation by the Arg/N-end rule pathway in naa10Δ cells include Kar4, Tup1, Gpd1, Ste11, and also, remarkably, the main Hsp90 chaperone (Hsc82) itself. Protection of Chk1 by Hsp90 could be overridden not only by ablation of the NatA Nt-acetylase but also by overexpression of the Arg/N-end rule pathway in wild-type cells. Split ubiquitin-binding assays detected interactions between Hsp90 and Chk1 in wild-type cells but not in naa10Δ cells. These and related results revealed a major role of Nt-acetylation in the Hsp90-mediated protein homeostasis, a strong up-regulation of the Arg/N-end rule pathway in the absence of NatA, and showed that a number of Hsp90 clients are previously unknown substrates of the Arg/N-end rule pathway.
Naa10 | Chk1 | Ubr1 | Ufd4 | protein degradation P roteins called chaperones promote the in vivo protein folding and counteract misfolding, maladaptive protein aggregation, and other perturbations of proteostasis (1) (2) (3) (4) . Hsp90 is an ATPdependent chaperone system that mediates the conformational maturation and stabilization of many proteins. Referred to as Hsp90 clients, these proteins include kinases, transcriptional regulators, and many other proteins that comprise at least 20% of a cellular proteome. The diversity of Hsp90 clients and the broad range of processes that involve Hsp90 underlie its necessity for cell viability in all eukaryotes (5) (6) (7) (8) (9) (10) (11) . Cochaperones of the ∼90-kDa Hsp90 comprise, in mammals, ∼30 distinct proteins. They participate in the delivery of clients to Hsp90 and contribute to related processes, including ATP hydrolysis by Hsp90 (12) . Because of its ability to modulate protein conformations, the Hsp90 system can either exacerbate or counteract the fitness-reducing effects of mutations in cellular proteins. This property of Hsp90 affects the standing genetic variation and thereby influences the impact of natural selection on rates and directions of evolution (13, 14) .
The N-end rule pathways comprise a set of proteolytic systems whose unifying feature is their ability to recognize proteins containing N-terminal (Nt) degradation signals called N-degrons, thereby causing the degradation of these proteins by the proteasome or autophagy in eukaryotes and by the proteasome-like ClpAP protease in bacteria ( Fig. 1) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) . The main determinant of an N-degron is a destabilizing Nt-residue of a protein. Many N-degrons become active through their enzymatic Nt-acetylation, Ntformylation, Nt-deamidation, Nt-arginylation, or Nt-leucylation. Studies over the last three decades have shown that all 20 amino acids of the genetic code can act, in cognate sequence contexts, as destabilizing Nt-residues. Consequently, many, possibly most, proteins in a cell are conditionally short-lived N-end rule substrates, either as full-length proteins or as protease-generated natural protein fragments (21, 27) . Recognition components of N-end rule pathways are called "N-recognins." In eukaryotes, N-recognins are E3 ubiquitin (Ub) ligases that can target N-degrons (Fig. 1) .
Regulated degradation of proteins or their fragments by N-end rule pathways has been shown to mediate a wide range of processes, including the sensing of oxygen, nitric oxide (NO), heme, and short peptides; the control of subunit stoichiometry in protein complexes; the elimination of misfolded proteins; the degradation of proteins retrotranslocated to the cytosol from other compartments; the regulation of apoptosis and repression of neurodegeneration; the regulation of DNA repair, transcription, replication, and chromosome cohesion/segregation; the regulation of G proteins, cytoskeletal proteins, autophagy, gluconeogenesis, peptide import, meiosis, immunity, circadian rhythms, fat metabolism, cell migration, cardiovascular development, spermatogenesis, and neurogenesis; the functioning of organs, including the brain, muscle, testis, and pancreas; and the regulation of leaf and shoot development, oxygen/NO sensing, and many other processes in plants (refs. 15-17, 21-24, 28 , and the references therein).
Eukaryotes contain three N-end rule pathways. One of them, the Arg/N-end rule pathway, targets unacetylated Nt-residues (Fig. 1B ) (18, (29) (30) (31) . N-terminal Arg, Lys, His, Leu, Phe, Tyr, Trp, Ile, and Met (if Met is followed by a bulky hydrophobic residue) are directly recognized by N-recognins (15, 27, 32) . In contrast, N-terminal Asn, Gln, Glu, and Asp (as well as Cys, under some conditions) are destabilizing because of the enzymatic deamidation of N-terminal Asn and Gln and the arginylation of N-terminal Asp, Glu, and (oxidized) Cys (33) (34) (35) (36) (37) .
In the yeast Saccharomyces cerevisiae, the Arg/N-end rule pathway is mediated by the Ubr1 N-recognin, a 225-kDa RINGtype E3 Ub ligase and a part of the targeting complex comprising the Ubr1-Rad6 and Ufd4-Ubc4/5 E3-E2 holoenzymes (Fig. 1B) (38) .
Significance
We found that the yeast Hsp90 chaperone system is greatly impaired in naa10Δ cells, which cannot N-terminally acetylate a majority of normally N-terminally acetylated proteins, including Hsp90 and its cochaperones. Hsp90 clients, including Chk1, Kar4, Tup1, Gpd1, Ste11, and even the Hsp90 chaperone (Hsc82) itself, became short-lived substrates of the Arg/N-end rule pathway in naa10Δ cells. Ubr1 targets the Chk1 kinase through its internal degron. Interactions of Hsp90 with Chk1 could be detected in wild-type but not in naa10Δ cells. These results revealed a major role of N-terminal acetylation in the Hsp90-mediated protein homeostasis and showed that a number of Hsp90 clients are previously unknown substrates of the Arg/N-end rule pathway.
Two substrate-binding sites of Ubr1 recognize N-degrons, whereas its other binding sites recognize internal degrons in proteins such as Cup9 or a variety of misfolded proteins (39) (40) (41) (42) (43) . Thus, physiological substrates of the Arg/N-end rule pathway comprise not only proteins bearing N-degrons but also proteins containing internal degrons.
Another N-end rule pathway is the Ac/N-end rule pathway. It recognizes N α -terminally acetylated (Nt-acetylated) residues (Fig.  1A) (20, 27, 28, 44) . N-degrons and E3 Ub ligases of the Ac/N-end rule pathway are called Ac/N-degrons and Ac/N-recognins, respectively. At least 60% of S. cerevisiae proteins and ∼90% of human proteins are cotranslationally and irreversibly Nt-acetylated by ribosome-associated Nt-acetylases (Fig. 1A) (45, 46) . In examined cases, the presence of the Nt-Ac group in a subunit of a protein complex increases the thermodynamic stability of the complex, because affinity-enhancing contacts by the Nt-Ac group cause a slower dissociation of the Nt-acetylated subunit (as compared with its unacetylated counterpart) from the rest of the complex (47) (48) (49) (50) . Many, possibly most, Nt-acetylated proteins contain Ac/N-degrons, whose regulation includes their steric shielding in cognate protein complexes (44) .
The third eukaryotic N-end rule pathway, the Pro/N-end rule pathway, is mediated by the GID Ub ligase. Gid4, a subunit of GID that functions as the Pro/N-recognin, targets proteins that bear the N-terminal Pro residue or a Pro at position 2, in addition to adjoining (and also required) sequence motifs ( Fig. 1C ) (21) . Physiological substrates of the Pro/N-end rule pathway include gluconeogenic enzymes, which are long-lived in cells deprived of glucose but are selectively destroyed upon return to glucose-replete conditions (21, 51, 52) .
We show here that the yeast Hsp90 chaperone system is greatly impaired in naa10Δ cells, which lack the NatA Nt-acetylase and therefore cannot Nt-acetylate a majority of normally Nt-acetylated proteins. By exploring this finding, we identified extensive connections between Hsp90 and the Arg/N-end rule pathway. These and related results revealed a major role of Nt-acetylation in the Hsp90-mediated protein homeostasis, a strong up-regulation of the Arg/N-end rule pathway in the absence of NatA, and also showed that a number of Hsp90 clients are previously unknown substrates of the Arg/N-end rule pathway.
Results
Promoter Reference Technique. Degradation assays used the promoter reference technique (PRT) (Fig. 2 A and B) (21) . In this method, one measures, during a chase, the ratio of a test protein to a long-lived reference protein, the mouse dihydrofolate reductase (DHFR). The reference protein and test proteins were The N-end rule pathways. N-terminal residues at the top of the diagram are indicated by singleletter abbreviations. Twenty DNA-encoded amino acids are arranged to delineate three sets of N-degrons in S. cerevisiae, corresponding to three N-end rule pathways. N-terminal Met is cited twice, because it can be recognized by the Ac/N-end rule pathway (as Nt-acetylated N-terminal Met) and by the Arg/N-end rule pathway (as unacetylated N-terminal Met). N-terminal Cys is also cited twice, because it can be recognized by the Ac/N-end rule pathway (as Ntacetylated Cys) and by the Arg/N-end rule pathway (as an oxidized, Nt-arginylatable N-terminal Cys, denoted as Cys* and formed in multicellular eukaryotes but apparently not in unstressed S. cerevisiae). coexpressed on a low-copy plasmid from two identical P TDH3 promoters containing additional DNA elements developed by others (53) . Once transcribed into an mRNA, these elements form 5′-RNA aptamers that can bind to tetracycline (Tc), thereby repressing translation of that mRNA in cis (Fig. 2B ). This PRT design improves degradation assays in two independent ways: by providing a reference protein and by allowing chases that involve a genespecific (Tc-mediated) repression of translation.
Chk1 Kinase Is Short-Lived in naa10Δ Cells. This work began with a finding about the S. cerevisiae mitotic checkpoint kinase Chk1 (SL-Chk1, bearing N-terminal Ser-Leu) (54) . C-terminally flagtagged wild-type SL-Chk1 3f was relatively long-lived in wildtype cells but became short-lived in naa10Δ (ard1Δ) cells, which lacked the NatA Nt-acetylase ( Fig. 2 C and E and SI Appendix, Fig. S2 A, C, and D) .
The accelerated degradation of SL-Chk1 3f in naa10Δ cells was manifested, in part, by much lower prechase (time-zero) levels of SL-Chk1 3f in these cells (Fig. 2 C and E and SI Appendix, Fig. S2 A, C, and D).
35
S-pulse-chases with SL-Chk1 3f produced similar results (SI Appendix, Fig. S2B ). We could ascribe the decreased prechase levels of SL-Chk1 3f in naa10Δ cells to its faster degradation (rather than to a decreased synthesis of Chk1), inasmuch as these assays used PRT and its built-in reference protein (Fig. 2B) . As shown earlier, prechase effects analogous to those in naa10Δ vs. wild-type cells stem from the accelerated destruction of nascent and/or newly formed proteins (15, 27, 44) . This aspect of SLChk1 3f degradation was particularly prominent in naa10Δ cells ( Fig. 2 C and E and SI Appendix, Fig. S2 A, C, and D) .
The faster degradation of SL-Chk1 3f in naa10Δ cells was NatA-specific: This effect was absent in naa20Δ cells (which lacked the NatB Nt-acetylase) and in naa30Δ cells (which lacked the NatC Nt-acetylase) (Fig. 2G ). An ectopic expression of NatA (Naa10) in naa10Δ cells (monitored by antibody to Naa10) restored the relative stability of SL-Chk1 3f (Fig. 3A) . CHX-chases, using PRT with wild-type SL-Chk1 3f , were performed at 30°C for 0, 20, 60, and 120 min, with wild-type (lanes 2-5), naa10Δ (lanes 6-9), ubr1Δ (lanes 10-13), and naa10Δ ubr1Δ (lanes 14-17) S. cerevisiae. Extracts were prepared from cells withdrawn at the indicated times of a chase. Proteins in an extract were fractionated by SDS/PAGE, followed by immunoblotting with anti-flag and anti-HA antibodies. (D) As in C, but CHX-chases, with the SK-Chk1 3f mutant, were for 0, 1, and 2 h, with wild-type (lanes 2-4), naa10Δ (lanes 5-7), ubr1Δ (lanes 8-10), and naa10Δ ubr1Δ (lanes 11-13) S. cerevisiae. (E and F) Quantification of data in C and D, respectively. For curve designations, see the keys below the immunoblots in C and D. All degradation assays in this study were performed at least twice, yielding results that differed by less than 10%. (G) As in C, but CHX-chases, with wild-type SL-Chk1 3f , were for 0, 1, and 2 h, with wild-type (lanes 2-4), naa10Δ (lanes 5-7), naa20Δ (lanes 8-10), and naa30Δ (lanes 11-13) S. cerevisiae. In C, D, and G, lane 1 shows kDa markers and blue stars denote 25-, 37-, 50-, and 75-kDa proteins.
Chk1 as a Substrate of the Arg/N-End Rule Pathway in naa10Δ Cells.
The E3 Ub ligases Ubr1 and Ufd4 are a part of the targeting apparatus of the Arg/N-end rule pathway (Fig. 1B) . Remarkably, the ablation of either Ubr1 or Ufd4 abrogated the accelerated degradation of SL-Chk1 3f in naa10Δ cells. SL-Chk1 3f was as stable in ubr1Δ naa10Δ and ufd4Δ naa10Δ double mutants as it was in wildtype cells, despite the absence of the NatA (Naa10) Nt-acetylase in double mutants and in contrast to the rapid degradation of SLChk1 3f in single-mutant naa10Δ cells (Figs. 2 C and E and SI Appendix, Fig. S2 A, C, and D). As would be expected (Fig. 1B) , the degradation of SL-Chk1 3f required the proteasome (Fig. 4D) .
Degradation of Chk1 in naa10Δ Cells Does Not Involve the Cup9
Regulon. Cup9, a transcriptional repressor of a regulon containing ∼50 genes, is conditionally destroyed by the Arg/N-end rule pathway through an internal degron of Cup9 (39) . It was conceivable that the tripartite Cup9-Tup1-Ssn6 repressor complex (39) might dissociate more rapidly in the absence of NatA-mediated Ntacetylation, because of the "affinity" effect of Nt-Ac groups (described in the Introduction). This effect would lead to a faster degradation of Cup9 by the Arg/N-end rule pathway in naa10Δ cells and, consequently, to an induction of the Cup9 regulon, whose functions are incompletely understood. We therefore asked whether the faster degradation of SL-Chk1 3f in naa10Δ cells might be mediated by the Arg/N-end rule pathway indirectly, through a faster destruction of Cup9 and the resulting up-regulation of a member of the Cup9 regulon (e.g., an uncharacterized Ub ligase) that would accelerate the degradation of SL-Chk1 3f in naa10Δ cells. This model was found to be incorrect, inasmuch as SL-Chk1 3f remained relatively long-lived in cup9Δ cells, in which the Cup9 regulon becomes derepressed (Fig. 4E) (39) . To address the degradation of endogenous SL-Chk1, we replaced the chromosomal CHK1 gene with a DNA segment that expressed wild-type SL-Chk1 C-terminally tagged with myc (SLChk1 9m ) from the endogenous P CHK1 promoter. The prechase (time-zero) level of SL-Chk1 9m in wild-type cells was ∼2.5-fold lower than in ubr1Δ cells (which lacked the Arg/N-end rule pathway), confirming that a large fraction of the endogenous SLChk1 9m was destroyed by the Arg/N-end rule pathway in wildtype cells (SI Appendix, Fig. S3 C and D) . Moreover, the prechase level of endogenous SL-Chk1 9m was further decreased in naa10Δ cells, becoming ∼4.7-fold lower than in ubr1Δ cells (SI Appendix, Fig. S3 C and D) . These findings were qualitatively similar to the results with (moderately) overexpressed SL-Chk1 3f ( Fig. 2 C and E and SI Appendix, Fig. S2 A, C, and D). Might a small unacetylated Nt-residue (such as Ser) followed by a bulky hydrophobic residue (such as Leu) function, in the contexts of SL-Chk1 3f and naa10Δ cells, as a previously unknown N-degron? To address this question, we constructed position-1, 2 mutants of SL-Chk1 3f . Both wild-type SL-Chk1 3f and its mutants SD-Chk1 3f and SF-Chk1 3f were predicted substrates of the NatA Nt-acetylase. In contrast, the SK-Chk1 3f and SR-Chk1 3f mutants were unlikely to be Nt-acetylated in wild-type cells, because a position-2 basic residue impedes Nt-acetylation in yeast. The PS-Chk1 3f and SP-Chk1 3f mutants, which contained Pro at positions 1 and 2, respectively, were not Nt-acetylated in wild-type cells (45) .
The results with XZ-Chk1 3f proteins (X = S, P; Z = L, D, F, K, R, P), including wild-type SL-Chk1 3f , were essentially indistinguishable. All these proteins were degraded relatively slowly in (Fig. 2B) , with wild-type SL-Chk1 3f , for 0, 1, and 2 h, with naa10Δ S. cerevisiae carrying a high-copy plasmid that expressed Naa10 from the P GAL promoter. Lane 1, kDa markers. Blue stars denote 20-, 25-, 37-, 50-, and 75-kDa markers, respectively. Lanes 2-4 and 5-7, cells (containing vector alone) in glucose and galactose medium, respectively. Lanes 8-10 and 11-13 are as in lanes 2-4 and 5-7, respectively, but with cells containing the P GAL -NAA10 plasmid. The presence of Naa10 was verified directly, using an affinity-purified antibody to Naa10 (bands in lanes 11-13, Approximately 60% of proteins in the S. cerevisiae proteome are predicted substrates of NatA (Naa10) (SI Appendix, Fig. S1 ) (45) . A parsimonious explanation of the accelerated degradation of SLChk1 3f in naa10Δ (NatA-lacking) cells is that in wild-type cells SLChk1 3f is shielded from the Arg/N-end rule pathway by a protective entity that becomes impaired in the absence of Nt-acetylation by NatA. Given the moderate overexpression of SL-Chk1 3f in our assays (Fig. 2B ), a protective entity had to be relatively abundant. The leading candidate was Hsp90, inasmuch as SL-Chk1 is a putative client of Hsp90 (55) .
Hsc82 and Hsp82 are two similar S. cerevisiae Hsp90 chaperones (5, 8) . Remarkably, our survey of the yeast Hsp90 system showed that not only Hsc82 and Hsp82, but also their cochaperones Aha1, Cdc37, Cns1, Cpr6, Cpr7, Hch1, Pih1, Ppt1, Rvb1, Rvb2, Sba1, Sse1, Sse2, Sti1, and Tah1 were either identified or predicted substrates of the NatA Nt-acetylase (SI Appendix, Figs. S1 and S5).
A bias this high was, a priori, an unlikely finding, because only ∼60% of the S. cerevisiae proteome are either identified or predicted substrates of NatA (45) . It is unknown whether the observed near-exclusive preference for NatA by the Hsp90 system (SI Appendix, Figs. S1 and S5) is functionally adaptive, i.e., whether this bias was caused by natural selection. The alternative interpretation is that this pattern resulted largely from a "fluctuation" in a quasi-neutral genetic drift. In either case, these results (SI Appendix, Ablation of Hsp90 Cochaperones Can Destabilize Chk1. We also found that SL-Chk1 3f was shorter lived in Naa10
+ cells lacking the cochaperones Sba1, Sse1, Sti1, or Tah1 (SI Appendix, Fig. S6 A and B). These assays used Tc-PRT chases ( Fig. 2 A and B) . Tc is at most weakly toxic, in contrast to highly toxic cycloheximide (CHX). The basal degradation of SL-Chk1 3f was faster in Tc-chases than in CHX-chases (e.g., compare Fig. 2 C and E with SI Appendix, Fig. S6C ). The cause of this difference was traced to the in vivo degradation of the Ubr1 N-recognin (a study of this aspect of the Arg/N-end rule pathway is under way). Although chases that used CHX (at present the standard translation inhibitor for degradation assays in the Ub field) produced results qualitatively similar to those with Tc, all chases at later stages of the present study were done using Tc, for the reason above.
Hsp90 Itself and Other Proteins as Substrates of Ubr1 in naa10Δ Cells.
We also examined other, quasi-randomly chosen non-Chk1 proteins for their degradation in naa10Δ cells vs. ubr1Δ cells. The Ubr1 targets thus identified were Kar4, a transcriptional regulator of pheromone responses; Tup1, a transcriptional corepressor; Gpd1, glycerol-3-phosphate dehydrogenase; Ste11, a kinase regulator of pheromone responses; and also, remarkably, Hsc82, the main Hsp90 chaperone (Fig. 3 D and E and SI Appendix, Figs. S3 E and F, S6D, and S7). Tup1 and Ste11 are clients of Hsp90 (56); Kar4 and Gpd1 may also be Hsp90 clients; and Hsc82 is itself an Hsp90.
The illuminating result that the Hsp90 (Hsc82) chaperone becomes vulnerable to the Arg/N-end rule pathway in naa10Δ cells ( (Fig. 2B) , with wild-type SL-Chk1 3f , for 0, 1, and 2 h, with wild-type (lanes 2-4), naa10Δ (lanes 5-7), cup9Δ (lanes 8-10), naa10Δ cup9Δ (lanes 11-13), and naa10Δ cup9Δ ubr1Δ (lanes 14-16) S. cerevisiae. Blue stars denote 25-, 37-, 50-, and 75-kDa markers.
lower than in wild-type cells (SI Appendix, Fig. S4 D and E) . Together, these findings strongly suggested that newly formed Hsc82 and Hsp82 are themselves clients of mature Hsc82/Hsp82, requiring the (unimpaired) Hsp90 system for their conformational maturation and protection from the Arg/N-end rule pathway. The Ubr1-mediated degradation of Hsc82 ( Fig. 3 D and E and SI Appendix, Figs. S4 D and E and S7 C and D) would account, at least in part, for the decreased protection, in naa10Δ cells, of Hsp90 clients such as SL-Chk1 3f ( Fig. 2 C and E) .
As already observed with SL-Chk1 3f , one aspect of the Ubr1-dependent patterns of degradation of Kar4, Tup1, Gpd1, Ste11, and Hsc82 was a significant increase in the prechase (time-zero) level of a test protein in ubr1Δ cells (which lacked the Arg/N-end rule pathway), as compared with, e.g., naa10Δ cells. Particularly clear examples of this increase were Hsc82, Ste11, and Gpd1 ( Fig. 3 D and E and SI Appendix, Figs. S6D and S7) .
A parsimonious interpretation of the relative flatness of decay curves in some of these cases (e.g., SI Appendix, Fig. S6D ), with the major change being a time-zero (prechase) alteration, is that "young" molecules of a protein (either cotranslationally or shortly after translation) are particularly vulnerable to the Arg/N-end rule pathway. The subsequent folding and quaternary structure formation (for example, mature Gpd1 is a homodimer) would make these proteins either partly or completely resistant to the Ubr1-mediated degradation through the shielding of a cognate degron and/or through a higher resistance to the unfolding of a targeted protein by the 26S proteasome. Conformational maturation of the above (and other) proteins can be partly reversible and takes place, at least in part, through their (protective) interactions with the Hsp90 system. Thus impairment of Hsp90 in naa10Δ cells increases the vulnerability of some Hsp90 clients, such as conditional Ubr1 substrates, to attacks by the Arg/N-end rule pathway.
An extensively analyzed precedent for the non-first-order (nonexponential) degradation kinetics by the Arg/N-end rule pathway was X-β-galactosidase (X-β-gal) bearing a destabilizing N-terminal residue (18) . These first (engineered) Arg/N-end rule substrates were vulnerable to the targeting by Ubr1 cotranslationally and/or shortly after translation. The subsequent formation of an X-β-gal homotetramer led to the nearly (but not quite) complete cessation of the degradation of a "mature" X-β-gal tetramer by the Arg/N-end rule pathway (15, 18, 19) . Later studies have shown that a non-first-order degradation kinetics is also a frequent aspect of proteolysis by the Ub system at large, resulting, primarily, from the same causes of time-dependent protein folding and formation of protein complexes (44, (57) (58) (59) .
As shown below, Ubr1 recognizes an internal, C terminusproximal degron of SL-Chk1. It is likely (but remains to be verified) that Kar4, Tup1, Gpd1, Ste11, and Hsc82 also bear Ubr1-specific internal degrons (as distinguished from N-degrons). Overall, ∼60% of 11 examined yeast proteins were identified as substrates of the Arg/N-end rule pathway in naa10Δ cells. Given this percentage and the quasi-random selection of proteins for these experiments, it is possible, indeed likely, that roughly a half of natural Hsp90 clients, i.e., ∼10% of the cellular proteome, will eventually be identified as conditional (Hsp90 state-dependent) substrates of the Arg/N-end rule pathway.
Overexpression of Ubr1-Ufd4 Destabilizes Chk1 in Wild-Type Cells.
Natural levels of Ubr1 are rate-limiting in the Arg/N-end rule pathway (15) . We therefore asked whether co-overexpression of Ubr1 and Ufd4, two interacting Ub ligases of the Arg/N-end rule pathway (Fig. 1B) , might accelerate the degradation of SL-Chk1 3f in wild-type cells, despite the presence of the NatA Nt-acetylase. Remarkably, we found that they did so (Fig. 5 A and B) . This result strongly suggested that the rate of degradation of an Hsp90 client such as SL-Chk1 3f is determined by a dynamic partitioning of SLChk1 3f between a protected Hsp90-bound state and a "free" state vulnerable to the Arg/N-end rule pathway.
The Endogenous Arg/N-End Rule Pathway Is Up-Regulated in naa10Δ
Cells. We also asked whether the Arg/N-end rule pathway might become naturally up-regulated in naa10Δ cells, which exhibited the accelerated degradation of SL-Chk1 3f ( Fig. 2 C and E and SI Appendix, Fig. S3 A, C, and D) . We began by comparing, using an affinity-purified antibody to S. cerevisiae Ubr1 (60), the levels of Ubr1 in wild-type vs. naa10Δ cells, with ubr1Δ cells as a negative control ( Fig. 3 B and C) . Despite the high sensitivity of this antibody [it could detect, by immunoblotting, down to ∼2 ng of Ubr1 (60)], the levels of endogenous Ubr1 in wild-type cells [500-1,000 Ubr1 molecules per haploid cell in exponential growth (38) ] were low enough to make these measurements technically challenging. Nevertheless, we reproducibly observed an ∼2.5-fold increase of the endogenous, untagged Ubr1 in naa10Δ cells as compared with wild-type cells (Fig. 3 B and C) .
In a conceptually independent set of assays, we used X-β-gal (in which X = His or Tyr) as Ub fusion-based reporters of the Arg/N-end rule pathway (15, 18, 19) . N-terminal His and Tyr are recognized by Ubr1 through its type-1 site (this site binds to basic Nt-residues) and type-2 site (this site binds to bulky hydrophobic Nt-residues), respectively (Fig. 1B) . In agreement with the higher levels of Ubr1 in naa10Δ cells (Fig. 3 B and C) , the degradation of His-β-gal and Tyr-β-gal was much faster in naa10Δ cells than in wild-type cells (see Fig. 7 C-E). A strong up-regulation of the Arg/N-end rule pathway in the absence of NatA provides a glimpse of still unexplored circuits that regulate the levels of pathway's components and the activity of this proteolytic system. yielded similar results, except that the effect of Ubr1 was now completely gone (SI Appendix, Fig. S6 A and C) . Thus, a degron recognized by Ubr1 is located largely within the last 25 residues of the 527-residue Chk1.
Mapping the Chk1 Degron by Two-Hybrid Binding Assays. We recently used two-hybrid assays (61) to map the recognition of a degron by its cognate E3 Ub ligase (21) . Application of this method to interactions between Chk1 and the Ubr1 E3 is shown in Fig. 6A . Controls included immunoblotting to verify the expression of two-hybrid fusions and also confirming that bindingpositive fusions did not stay positive in assays with one of two fusions (e.g., SI Appendix, Fig. 6 A, 1) . In agreement with truncation-degradation assays (SI Appendix, Fig. S6 ), the in vivo interaction between Ubr1 and the 527-residue Chk1 could be abrogated by deleting the last 25 residues of Chk1 (Fig. 6A) .
Mapping the Chk1 Degron by Split-Ubiquitin Binding Assays. In addition and independently, Ubr1-Chk1 interactions were also analyzed by the split-Ub assay. In this method, test proteins are expressed as fusions, respectively, to a C-terminal half of Ub (C ub ) and to its mutant N-terminal half (N ub ). Interactions between test proteins would reconstitute a quasi-native Ub moiety from C ub and mutant N ub . The resulting cleavage of a C ub -containing fusion by deubiquitylases downstream from the Ub moiety serves as a readout of this technique (62, 63) .
In agreement with truncation-degradation and two-hybrid assays ( Fig. 6A and SI Appendix, Fig. S6 ), Ubr1 could bind, in splitUb assays, to the full-length SL-Chk1 1-527 but not to SL-Chk1 (SI Appendix, Figs. S4A and 6 B, 1 and 4). Moreover, the Ubr1-recognized region of SL-Chk1 1-527 may be as small as 10 or fewer C-terminal residues. Specifically, neither SL-Chk1 1-510 nor SLChk1 1-517 could bind to Ubr1, in contrast to wild-type SL-Chk1 ( Fig. 6B ).
Degron-Specific Ubiquitylation of Chk1 in a Defined in Vitro System.
We also developed a ubiquitylation system that comprised the following purified S. cerevisiae proteins: His 6 -Ub; the Uba1 E1 enzyme; the Rad6 E2 enzyme; the His 6 -Ubc4 E2 enzyme; the C-terminally flag-tagged Ufd4 f E3; the N-terminally flag-tagged f Ubr1 E3; the C-terminally myc-flag-tagged full-length SLChk1 (Fig. 7A) . This completely defined in vitro system could reproduce the recognition of Chk1 by Ubr1 that was inferred from truncation-degradation, two-hybrid, and splitUb assays (Fig. 6 A and B and SI Appendix, Fig. S6 ). SLChk1 1−527 m−f was polyubiquitylated if the system contained ATP, Ub, Uba1, and at least Ubr1 and Rad6. Ufd4 and Ubc4 had no effect in this system, and Ufd4-Ubc4 by themselves, in the absence of Ubr1, did not support polyubiquitylation of SLChk1 1−527 m−f ( Fig. 7 B and C) . Crucially, the complete system containing SL-Chk1 1−502 m−f , which lacked the 25 C-terminal residues of SL-Chk1 1−527 m−f , could polyubiquitylate the latter but not the former protein (Fig. 7C, lane 12) .
In agreement with degron-mapping results (Figs. 6 A and B and 7 and SI Appendix, Fig. S6 ), alignments of Chk1 amino acid sequences from several yeasts (S. cerevisiae, Candida glabrata, Lachancea fermentati, and Kluyveromyces lactis) revealed a particularly strong conservation of the last ∼25 residues, in comparison, e.g., with the next ∼30 residues upstream of that region (Fig. 6D ). The few divergences over the last 25 residues of Chk1 involved solely changes to similar residues (Fig. 6D) . In sum, the minimal degron of SL-Chk1 1-527 comprises its ∼10 Cterminal residues (Fig. 5B) , but the complete degron is larger, as suggested, in particular, by a weak but detectable Ubr1 dependence of the degradation of SL-Chk1 , which lacked the last 25 residues of Chk1 (SI Appendix, Fig. S8B ).
Chk1-Hsp90 Interactions in Wild-Type but Not in naa10Δ Cells. We found that split-Ub assays (62, 63) could also detect in vivo interactions between full-length Chk1 and Hsc82, the main Hsp90 chaperone (Fig. 6 C, 1 and 2 and SI Appendix, Fig. S4 B, 3) . This detection required the absence of obstruction of the C terminus of the Hsc82 moiety. Specifically, a split-Ub configuration in which the C terminus of Hsc82 was linked to the C ub -activator moiety yielded a barely detectable signal (SI Appendix, Fig. S4 B, 3 and 4) , in agreement with the importance of the C terminus of Hsc82, including its dimerization and its interactions with cochaperones (8) .
Remarkably, the same split-Ub assays that yielded a robust Chk1-Hsc82 interaction signal in wild-type cells produced virtually no interaction signal in naa10Δ cells (Fig. 6C and SI Appendix, Fig. S4C ). This striking difference could not be caused by a failure of the split-Ub assay itself, because the interactions between Ubr1 and Chk1 were readily detected by split-Ub in either wild-type or naa10Δ cells (SI Appendix, Fig. S4 B, 1 and 2) .
The near-abrogation of the in vivo binding of Chk1 to its protector Hsc82 in naa10Δ cells (in contrast to wild-type cells) illuminated still another aspect of the impairment of the Hsp90 system (Fig. 2B) , with wild-type SL-Chk1 3f , for 0, 1, and 2 h, in wildtype S. cerevisiae carrying a high-copy plasmid that expressed both flag-tagged Ubr1 ( f Ubr1) and Hsv-tagged Ufd4 (Ufd4 hsv ) from the bidirectional P GAL1,10 promoter. Lanes 2-4 and 5-7: cells containing the P GAL1,10 -UBR1/UFD4 plasmid in glucose and galactose medium, respectively. in the absence of NatA. The mechanism of this effect (Fig. 6C and SI Appendix, Fig. S4C ) remains to be understood. It may involve not only Hsc82 and Hsp82, because both they and their ∼15 cochaperones are either identified or predicted substrates of the NatA Ntacetylase that is absent in naa10Δ cells.
Discussion
This study revealed a major impairment of the Hsp90 chaperone in naa10Δ S. cerevisiae, pinpointed causes of this perturbation, showed that the Arg/N-end rule pathway is strongly up-regulated in the absence of the NatA (Naa10) Nt-acetylase, identified several substrates of the Arg/N-end rule pathway, and suggested specific functions of Nt-acetylation in the physiological regulation of the Hsp90 system. In the absence of the NatA Nt-acetylase, roughly 2,000 normally Nt-acetylated yeast proteins lack this modification (45) . In particular, the entire Hsp90 system (Hsc82, Hsp82, and its ∼15 cochaperones) would not be Nt-acetylated in naa10Δ cells (SI Appendix, Fig. S5 ).
One manifestation of Hsp90 impairment in naa10Δ cells was a much faster degradation of Chk1 (a mitotic checkpoint kinase and Hsp90 client) by the Arg/N-end rule pathway, which was found to recognize a specific C terminus-proximal degron of Chk1 (Figs.  1B, 2, 6, and 7) . The protection of Chk1 by Hsp90 could be overridden not only by the absence of the NatA Nt-acetylase but also by overexpression of the Arg/N-end rule pathway in wild-type cells (Fig. 5 A and B) . This result indicated that the rate of degradation of Chk1 is determined by its dynamic partitioning between a protected Hsp90-bound state and a free state vulnerable to the Arg/N-end rule pathway. Therefore it was possible that the Arg/N-end rule pathway might be naturally up-regulated in naa10Δ cells, because that upregulation would account, at least in part, for the observed destabilization of Chk1 in these cells. The Arg/N-end rule pathway was indeed found to be much more active in naa10Δ cells than in wild-type cells (Figs. 3 B and C and 5 C-E) . Yet another result that revealed a distinct cause of Hsp90 impairment in the absence of NatA was the degradation of Hsc82, the main Hsp90 chaperone, by the Arg/N-end rule pathway in naa10Δ cells and the corresponding (approximately twofold) decrease in the steady-state level of Hsc82+Hsp82 in the absence NatA, relative to wild-type cells (Fig. 3 D and E and SI Appendix, Fig. S7 C and D) . The degradation of the Hsp90 chaperone (Hsc82 and presumably Hsp82 as well) by the Arg/N-end rule pathway in naa10Δ cells accounts, at least in part and independently of other causes, for the decreased protection of Hsp90 clients under these conditions. These and related results strongly suggested three causes of the Hsp90 impairment in naa10Δ cells that are not mutually exclusive. A fourth cause, also stated below, is hypothetical but verifiable and would be physiologically important if correct.
i) A strongly increased activity of the Arg/N-end rule pathway in the absence of NatA and, consequently, an increased ability of this pathway to compete with Hsp90 for its clients such as, for example, Chk1. This finding (Figs. 3 B and C, and 5 C-E) provides a glimpse of still unexplored circuits that regulate components of the Arg/N-end rule pathway and its proteolytic activity. ii) An intrinsic weakening of Hsp90 in naa10Δ cells, because nearly all its components (Hsc82, Hsp82, and their ∼15 cochaperones) are NatA substrates (SI Appendix, Fig. S5 ).
The resulting impairment of protein interactions that normally involve the Nt-Ac groups of Nt-acetylated proteins (see the Introduction) is likely to underlie the observed degradation of Hsp90 (Hsc82) by the Arg/N-end rule pathway in naa10Δ cells (Fig. 3 D and E and SI Appendix, Figs. S4 D and E and S5 C and D). iii) In addition to a decreased steady-state level of the Hsc82 (Hsp90) protein in naa10Δ cells (see item ii above), one would also expect the impairment of the Hsp90 system as a whole in the absence of NatA. The functioning of Hsp90 involves its transient binding to cochaperones, with some of them carrying bound clients (12) . Given the role of Nt-Ac groups in modulating (usually enhancing) protein interactions within cognate protein complexes (49), decreased affinities among most components of the Hsp90 system, which are not Nt-acetylated in naa10Δ cells, would be expected to perturb both the delivery of clients to Hsp90 by cochaperones and other aspects of this circuit, based on transient protein interactions.
Our detection, via split-Ub assays in wild-type cells, of the in vivo interaction between Hsp90 (Hsc82) and its client Chk1 and the remarkable near-ablation of this interaction in naa10Δ cells (Fig. 6C and SI Appendix, Fig. S4B, 3 and 4 ) strongly support this view of the Hsp90 system in cells lacking NatA.
iv) The absence of a normally present Nt-Ac group in a subunit of a protein complex can decrease the subunit's affinity for the rest of the complex from ∼10-fold to ∼1,000-fold (48, 49) . Thus, the numerous and normally Nt-acetylated S. cerevisiae proteins that lack this modification in naa10Δ cells would form otherwise cognate in vivo complexes that would be prone to (reversible) dissociation. Away from their natural protein ligands, at least some dissociated free subunits would be likely to act as conformationally disordered Hsp90 clients, thereby competing with normal Hsp90 clients and, consequently, impairing protein homeostasis for that reason alone. Note that some of these free proteins, dissociated from complexes that would be less stable in naa10Δ cells, may even not require assistance by Hsp90 cochaperones for binding to Hsp90.
(The fraction of in vivo Hsp90 clients that can interact with Hsp90 directly, without their initial binding to cochaperones, is not known.) This fourth mechanism of Hsp90 impairment in naa10Δ cells remains to be addressed experimentally.
One feature of naa10Δ S. cerevisiae is the remarkably broad range of this mutant's abnormal phenotypes. They include cellcycle and mating defects as well as temperature sensitivity and perturbations of protein synthesis and degradation (27, 46, 64) . Our finding of specific connections between the Hsp90-mediated protein homeostasis and the Nt-acetylation of proteins by NatA has revealed a major reason for the multiplicity of naa10Δ effects, given the wide range of Hsp90 functions and their impairment in the absence of NatA. Strong evolutionary conservation of the Hsp90 system, Nt-acetylases, and N-end rule pathways indicates that the results of this study are also relevant to multicellular eukaryotes, including mammals.
Given the advances described above, an important question is whether a perturbation of the Hsp90 system that is similar to the impairment observed with naa10Δ S. cerevisiae can also occur in nonmutational settings. Decreased NatA activity can be caused, for example, by a stress-mediated down-regulation of Ac-CoA, the co-substrate of Nt-acetylases. Indeed, physiologically relevant changes in the levels of Ac-CoA have been shown to affect both the efficacy of Nt-acetylation and the sensitivity of mammalian cells to apoptotic signals (65) . It would be illuminating, therefore, to determine a role that the Hsp90 system plays in specific connections between Ac-CoA, Nt-acetylation, and apoptosis, particularly because the Arg/N-end rule pathway has already been shown to be a regulator of apoptosis (22, 29) .
Changes in the rate of Nt-acetylation of cellular proteins by NatA can also be caused by altered levels of the NatA Nt-acetylase and/or changes in its enzymatic activity. The expression of NatA in the plant Arabidopsis thaliana and, correspondingly, the in vivo Nt-acetylation of NatA substrates have been found to be controlled by the phytohormone abscisic acid (66) . Remarkably, a natural decrease of NatA during drought was shown to be required for plants' tolerance to drought (66) . Analogous regulated changes in the levels of NatA and/or Ac-CoA, as well as connections between these changes and either the Hsp90 system or the Arg/N-end rule pathway, remain to be explored in other organisms, including mammals.
Materials and Methods
For further information, see SI Appendix, SI Materials and Methods.
Yeast Strains, Media, and Genetic Techniques. The S. cerevisiae strains used in this work are described in SI Appendix, Table S1 . Standard techniques were used for strain construction and transformation. S. cerevisiae media included yeast extract/peptone/dextrose (YPD) and Synthetic Complete (SC) medium (Sigma-Aldrich).
Construction of Plasmids. The plasmids used in this study are described in SI Appendix, Table S2 . Construction details are described in SI Appendix, SI Materials and Methods. All final constructs were verified by DNA sequencing.
PRT-Based CHX-Chases, Tc-Chases, and 35 S-Pulse-Chase Assays. The PRT method is described in Fig. 2 A and B . Details of PRT-based CHX-chases and Tc-chases are described in SI Appendix, SI Materials and Methods. Protein bands visualized by immunoblotting were quantified using an Odyssey-9120 Imaging System (LI-COR).
Two-Hybrid Assays. Yeast-based two-hybrid binding assays (61) were carried out largely as described previously (21) . "AD" and "DBD" refer to activation domain and DNA-binding domain, respectively. In both two-hybrid and split-Ub assays (described below), the expression of HIS3 (the ultimate readout of both assays), in otherwise His − cells, was a function of affinity between test proteins.
Split-Ub Assays. Yeast-based split-Ub binding assays (62, 63) were carried out largely as described previously (21) .
In Vitro Ubiquitylation Assay. Protein components of the assay were expressed in Escherichia coli or S. cerevisiae. The assay was carried as described in SI Appendix, SI Materials and Methods. Secondary antibodies for immunoblotting were Li-Cor IRDye-conjugated goat anti-mouse 800CW (Li-Cor, C60405-05) or anti-rabbit 680RD (Li-Cor, C51104-08). Affinity-purified rabbit antibody to S. cerevisiae Ubr1 was produced as described previously (1, 2). Fluorescence patterns were detected and quantified using Odyssey-9120 (Li-Cor, Lincoln, NE).
Affinity-purified rabbit antibody to S. cerevisiae Naa10 was produced by immunizing two rabbits (at Covance, Inc., Sherman Oaks, CA) with ~5 mg of purified Naa10. The latter was produced by expressing His10-Ub-Naa10 in E. coli from pJO162 (Table S2 ) and purifying untagged Naa10 by affinity chromatography and the cleavage by a deubiquitylase as described previously (3). Antisera to Naa10 were purified by TALON affinity chromatography (Clontech), with immobilized Naa10. The resulting antibody was then further purified through "negative" selection using a nitrocellulose membrane with immobilized extract from naa10∆ S. cerevisiae cells. For immunoblotting results with this antibody, see Figure 3A , lanes 11-13.
Other reagents included "complete protease inhibitor cocktail" tablets (Roche, Yeast Strains, Media, and Genetic Techniques. The S. cerevisiae strains used in this work are described in Table S1 . Standard techniques (4) were used for strain construction and transformation. S. cerevisiae JOY379, JOY439, JOY440, JOY441, JOY442, JOY443, JOY468, JOY487, JOY498, JOY505 and JOY529 were constructed using the PCR-based gene targeting method (5) and pFA6a-KanMX6, HphNT1 or NatNT2 modules (6) . S. cerevisiae JOY512, JOY513 and JOY514 were constructed by extending, using standard recombination methods (6),
the endogenous CHK1 open reading frame (ORF) in the strains BY4742, CHY271 and JOY379, respectively (Table S1) , with a sequence encoding nine consecutive c-myc epitope tags from either pYM20 or pYM18. S. cerevisiae media included YPD (1% yeast extract, 2% peptone, 2%
glucose; only most relevant components are cited); SD medium (0.17% yeast nitrogen base, 0.5% ammonium sulfate, 2% glucose); and synthetic complete (SC) medium (0.17% yeast nitrogen base, 0.5% ammonium sulfate,2% glucose), plus a drop-out mixture of compounds required by specific auxotrophic strains.
Construction of Plasmids.
The plasmids used in this study are described in Tables S2.
To construct the DHFR-reference part of the PRT vector pJO622, the multipartite PTDH3
promoter, containing three tetracycline (Tc) aptamers, was amplified from PTDH3-tc3-3×ha (Table   S2 ) (7), and the flagDHFRha ORF was amplified from pJO379. PCR products were digested with SacI/EcoRI and EcoRI/XhoI, respectively, and ligated into SacI/XhoI-cut pRS413-Met25. The PRT-based pJO624 (Table S2) , used throughout this study, was constructed by amplifying PTDH3-tc3, S. Cln3-3-flag, the cyc1 terminator, and PTDH3-tc3-flagDHFRha from pJO622 (Table S2 ). The resulting DNA was digested with SacII/AscI, AscI/NotI, NotI/FseI and FseI/XmaI respectively, and ligated into SacII/XmaI-cut pRS313, yielding pJO624 (Table S2) .
For constructing a Chk1-expressing plasmid, the S. cerevisiae CHK1 ORF (amplified from S. cerevisiae genomic DNA) was digested with AscI/BglII and was ligated into AscI/BamHI-cut pJO624, yielding pJO630 (Table S2) . Otherwise identical plasmids encoding N-terminal mutants of Chk1 were produced using PCR, with a forward primer that contained a desired N-terminal mutation. Each PCR-amplified DNA fragment was digested with
AscI/BamHI and ligated into AscI/BamHI-cut pJO630. Other ORFs used in this study were amplified from S. cerevisiae genomic DNA and cloned by digesting with AscI/BamHI sites, followed by the cloning route described above.
Plasmids expressing Ub K48 -Y-eK βgal and Ub K48 -H-eK βgal from PRT-based plasmids, were constructed by amplifying DNA segments encoding, respectively, Ub K48 -Y-eK βgal and Ub K48 -H-eK βgal from pJO746 and pJO747 (Table S2 ). The resulting DNA fragments were digested with AscI/BamHI and ligated into AscI/BamHI-cut pJO699, yielding pJO752 and pJO753 (Table S2 ).
For split-Ub assays, full-length as well as C-terminally truncated Chk1, Hsc82, Ufd4 and Ubr1 ORFs were amplified from S. cerevisiae genomic DNA using appropriate primers that contained (asymmetric) SfiI sites at both ends. The resulting DNA fragments were digested with SfiI and ligated into SfiI-cut pDHB1 or pPR3-N (Table S2 ). To construct plasmids for two-hybrid assays, the full length S. cerevisiae UBR1 ORF, and either full-length or C-terminally truncated Chk1-encoding ORFs were cloned into the pDonor/Zeo via the BP recombination reaction of the Gateway system (8) that included the Gateway BP clonase II enzyme mix (Invitrogen). The resulting plasmids were pJO781, pJO930, pJO931, and pJO932 (Table S2) . Thereafter the LR Gateway reaction was carried out with the above plasmids and pGADCg for Gal4-AD expression or pGBKT7g for Gal4-DBD expression, using the Gateway LR clonase II enzyme mix (Invitrogen). The resulting plasmids were pJO794, pJH024, pJO028, and pJH030, respectively (Table S2) .
To construct pJO690, a high copy (2μ-based) plasmid that expressed Ufd4hsv and fUbr1 from the bidirectional PGAL1/10 promoter, a three-step procedure was used. First, a SacI/XhoI fragment was cut from pRS314-Gal1/10 (which contains PGAL1/10), and was ligated into SacI/XhoI-cut pRS426-Met25, replacing PMET25 of the original plasmid with the PGAL1/10. The resulting plasmid was pJO241. Second, the full-length UBR1 ORF (encoding the N-terminal flag tag as well) was amplified from pNTfUBR1 (Table S2 ) and digested with MfeI/XhoI. The resulting DNA fragment was ligated into EcoRI/XhoI-cut pJO241, yielding pJO689. Finally, the NotI/FseI fragment of the PCR-amplified UFD4 ORF that was followed by an hsv tag-coding DNA sequence, and the FseI/SacII-produced CYC1 terminator (amplified from S. cerevisiae genomic DNA were triply ligated into NotI/SacII-cut pJO689, yielding pJO690 (Table S2 ).
The plasmids pJO589 and pJO591, which encoded, respectively, S. cerevisiae Ubc4 and mono-Ub were constructed by ligating the NcoI/BamHI-digested PCR products of Ubc4 and mono-Ub ORFs into NcoI/BamHI-cut pET-15b, yielding pJO589 and pJO591, respectively (Table S2) . pJO663, which encoded His6 followed by the human rhinovirus (HRV) 3C protease site and the S. cerevisiae Rad6 moiety, was produced by overlap extension PCR (9) . Two overlapping DNA fragments, one of them bearing the NcoI site and encoding His6 as well as the HRV 3C protease site, and the other one bearing the BamHI site and encoding Rad6 were denatured and reannealed, so the they formed a partially duplex DNA that encompassed the HRV 3C segment. The resulting PCR-produced fragment was digested with NcoI/BamHI and ligated into NcoI/BamHI-cut of pET-11d. The resulting plasmid was pJO663 (Table S2 ).
Construction details for other plasmids are available upon request. All final constructs were verified by DNA sequencing.
PRT-based cycloheximide-chases and tetracycline-chases. S. cerevisiae were grown to A600 of ~ 1.0 in selective liquid media at 30°C, followed by treatment with cycloheximide 
35
S-pulse-chase assays. These assays were performed largely as described (1, (11) (12) (13) .
S. cerevisiae were grown at 30C to A600 of ~1 in 10 ml of SC medium. Cells were pelleted by centrifugation, gently resuspended, and washed in 0.8 ml of SD medium with required amino acids but without Met and Cys. Cell pellets were gently resuspended again in 0.4 ml of the same medium and incubated at 30C for 20 min and thereafter labeled for 2 min at 30°C with 0.16 mCi of 35 S-EXPRESS Met/Cys (Perkin-Elmer). Cells were pelleted again and resuspended in 0.3 ml of SD medium with required amino acids as well as unlabeled 10 mM methionine and 5 mM cysteine. Samples (0.1 ml) were taken at indicated time points, followed by preparation of extracts using Mini-Beadbeater-16 (BioSpec) (4 times for 15 sec each, with 5-min intervals on ice). The resulting extracts were clarified by centrifugation at 21,000g for 15 min, twice, and supernatants were processed for immunoprecipitation, using anti-flag antibody immobilized on magnetic beads (Sigma). Immunoprecipitates were analyzed by SDS-4-12% NuPAGE (Invitrogen) and autoradiography.
Two-hybrid assays. Yeast-based two-hybrid binding assays (14) were carried out largely as described previously (8) . S. cerevisiae AH109 (Table S1) (Table S1 ) as described previously (17) . The resulting proteins were purified from cell extracts by affinity chromatography, using anti-flag M2
antibody-magnetic beads as described previously (18), with slight modifications. S. cerevisiae To induce expression of N-terminally His6-tagged ubiquitin (His6-Ub) expression, pJO591 (Table S2 ) was transformed into BL21 (DE3) E. coli. 5 ml of overnight culture of transformed cells was inoculated into 0.4 l of LB medium containing 34 μg/ml chloramphenicol and 100 μg/ml ampicillin, followed by incubation at 37 °C for ~1 h to A600 of ~0.6. Expression of His6-Ub was induced with 1 mM isopropyl-D-thiogalactoside (IPTG) at 22°C overnight. Cells were harvested, thereafter, by centrifugation and frozen at -80°C. To overexpress N-terminally His6-tagged Ubc4 (His6-Ubc4), pJO589 (Table S2 ) was transformed into BL21 (DE3) E. coli. At A600 of ~0.5, IPTG was added to 1.6 l culture to the final IPTG concentration of 1 mM, followed by incubation at 37°C for 4 hr. N-terminally His6-tagged Rad6 (His6-Rad6) was similarly overexpressed from E. coli BL21 (DE3) transformed with pJO663 by adding 1 mM IPTG to 400 ml of culture at A600 of 0.6, then incubated overnight at 22 °C (Table S2) .
His6-Ub and other His6-tagged overexpressed proteins were purified using TALON affinity resin (Clontech) as described in the manufacturer's protocol, with slight modifications.
Briefly, 3-4 g of cell pellet were resuspended in 40 ml of xTractor buffer containing 1×protease inhibitor cocktail ("for bacterial cells"; Sigma) 1×PMSF, 1×DNase I, and 40 mg lysozyme, followed by gentle shaking for 20 min at 4°C. After centrifugation at 12,000g for 20 min at 4°C, the supernatant was transferred to a 50-ml tube containing 1 ml of pre-washed TALON resin.
After gentle shaking at 4°C for 1 hr, the slurry was transferred to a 10-ml polypropylene column, followed by two washes with equilibration buffer, one wash with wash buffer, and the elution of proteins with 10 ml of elution buffer (Clontech).
His6-Rad6 purification was done as described above, except that before the elution step, the TALON-bound His6-Rad6 was incubated, at 4°C overnight, in 0.5 ml of the cleavage buffer was changed to equilibration buffer using PD-10 column (GE Healthcare). The sample was incubated, then, with 0.5 ml of Talon resin at 4°C for 1 hr and the flow-through was collected.
Final protein samples were dialyzed against storage buffer (10% glycerol, 0.15 M NaCl, 5 mM β-mercaptoethanol, 50 mM HEPES, pH 7.5) overnight, followed by storage at -80°C.
In vitro ubiquitylation assay. Purified proteins for the assay were produced as described above. Purified S. cerevisiae Uba1 (Ub-activating enzyme, E1) was purchased from Boston Figure 2B) , with wt SL-Chk13f, for 0, 1 and 2 hr, with wild-type (wt) (lanes 2-4), naa10Δ (lanes 5-7), ubr1Δ (lanes 8-10), naa10Δ ubr1Δ (lanes 11-13), and doa10Δ ubr1Δ (lanes 14-16) S. cerevisiae. Extracts were prepared from cells withdrawn at indicated times of a chase. Proteins in an extract were fractionated by SDS-PAGE, followed by immunoblotting with anti-flag and anti-ha antibodies. The bands of Chk13f and fDHFRha are indicated.
(B) 35 S-pulse-chases, using PRT ( Figure 2B ), a 2-min pulse with 35 S-Met/Cys, and a CHX-chase afterward, with wt SL-Chk13f, for 0, 20 and 60 min, in wt (lanes 1-3) , naa10Δ (lanes 4-6), ubr1Δ (lanes 7-9), and naa10Δ ubr1Δ (lanes 10-13) S. cerevisiae. Extracts were prepared from cells withdrawn at indicated times of a chase, followed by precipitation of proteins with anti-flag magnetic beads, SDS-PAGE, and autoradiography.
(C) Lane 1, kDa markers. CHX-chases, using PRT ( Figure 2B ), with wt SL-Chk13f, for 0, 1 and 2 hr, with wt (lanes 2-4), naa10Δ (lanes 5-7), ubr1Δ (lanes 8-10), naa10Δ ubr1Δ (lanes 11-13), ufd4Δ (lanes 14-16), and naa10Δ ufd4Δ (lanes 17-19) S. cerevisiae. The bands of Chk13f and fDHFRha are indicated.
(D) Quantification of data in C. For curve designations, see the lower part of C. All chases in this study were performed at least twice, yielding results that differed by less than 10%. (A) Lane 1, blue stars denote 20, 25, 37, 50, and 75 kDa markers, respectively. CHX-chases, using PRT ( Figure 2B) , with wt SL-Chk13f, for 0, 1 and 2 hr, with wt (lanes 2-4), naa10Δ (lanes 5-7), ubr1Δ (lanes 8-10), naa10Δ ubr1Δ (lanes 11-13), hsc82Δ (lanes 14-16), and hsp82Δ (lanes 14-16) S. cerevisiae. Extracts were prepared from cells withdrawn at indicated times of a chase. Proteins in an extract were fractionated by SDS-PAGE, followed by immunoblotting with anti-flag and anti-ha antibodies. The bands of Chk13f and fDHFRha are indicated.
(B) Quantification of data in A. For curve designations, see the lower part of A. All chases in this study were performed at least twice, yielding results that differed by less than 10%.
(C) Ubr1-mediated degradation of the endogenous wt SL-Chk1, C-terminally tagged (at the endogenous CHK1 gene) with myc epitopes (Chk19m). Lane 1, kDa markers. CHX-chases with wt endogenous Chk19m, for 0, 1 and 2 hr, with wt (lanes 2-4), naa10Δ (lanes 5-7), and ubr1Δ (lanes 8-10) S. cerevisiae. With immunoblots of tubulin as a loading control.
(D) Quantification of data in C. For curve designations, see the lower part of C. All chases in this study were performed at least twice, yielding results that differed by less than 10%. (A) Split-Ub-based fusions of Ubr1 vs. full-length Chk1 1-527 (see the legend to the main Figure 6 for additional details) in wt S. cerevisiae. A1 and A2, either Ubr1 alone or Chk1 alone (negative controls). A3, split-Ub assay with both Chk1 and Ubr1. Expression of HIS3 (the ultimate readout of split-Ub assay), in otherwise His -cells, was a function of affinity between test proteins. Left panels in A-C are images of His-containing plates, on which all yeast strains grew. His-lacking plates, on which only His + cells grew, are on the right (see STAR Methods).
Fig. S5
. The known components of the S. cerevisiae Hsp90 system, save for Sgt1, are either identified or predicted substrates of the NatA (Naa10) Nt-acetylase. See also Fig. S1 , the main text, and references therein. Figure 2B ), with wt SL-Chk13f, for 0, 1, 2, and 4 hr, with wt (lanes 2-5), naa10Δ (lanes 6-9), sba1Δ (lanes 10-13), sse1Δ (lanes [14] [15] [16] [17] , sti1Δ (lanes 18-21), and tah1Δ (lanes 22-25) S. cerevisiae. Extracts were prepared from cells withdrawn at indicated times of a chase. Proteins in an extract were fractionated by SDS-PAGE, followed by immunoblotting with anti-flag and anti-ha antibodies. The bands of Chk13f and fDHFRha are indicated.
(B) Quantification of data in A. For curve designations, see the right part of A. All chases in this study were performed at least twice, yielding results that differed by less than 10%.
(C) Tetracycline (Tc)-based chases, using PRT ( Figure 2B ), with wt SL-Chk13f, for 0, 1, 2, and 4 hr, with wt ( lanes 1-4), naa10Δ (lanes 5-8), ubr1Δ (lanes 9-12) , and naa10Δ ubr1Δ (lanes 13-16) S. cerevisiae.
(D) Degradation of Gpd1. Lane 1, kDa markers. CHX-chases, using PRT ( Figure 2B ), with wt Gpd13f, for 0, 1, and 2 hr, with wt (lanes 2-4), naa10Δ (lanes 5-7), ubr1Δ (lanes 8-10), and naa10Δ ubr1Δ (lanes 11-13) S. cerevisiae. The bands of Gpd13f and fDHFRha are indicated. (A) Degradation of Ste11. Lane 1, blue stars denote 20, 25, 37, 50, 75 and 100 kDa markers, respectively. Tetracycline (Tc)-chases, using PRT ( Figure 2B) , with wt Ste113f, were for 0, 20, 60, and 120 min with wt (lanes 2-5), naa10Δ (lanes 6-9), and ubr1Δ (lanes 10-12) S. cerevisiae. Extracts were prepared from cells withdrawn at indicated times of a chase. Proteins in an extract were fractionated by SDS-PAGE, followed by immunoblotting with anti-flag and anti-ha antibodies. The bands of Ste113f (see the main text) and fDHFRha are indicated.
(C) Degradation of Hsc82. Tetracycline (Tc)-chases, using PRT ( Figure 2B) , with wt Hsc823f, were for 0, 1, 2, 4, and 8 hr, with wt (lanes 2-5), naa10Δ (lanes 6-9), and ubr1Δ (lanes 10-13) S. cerevisiae.
(D) Quantification of data in C. For curve designations, see the lower part of C. All chases in this study were performed at least twice, yielding results that differed by less than 10%. 
